Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

4.65
Delayed Data
As of Sep 02
 -0.04 / -0.85%
Today’s Change
4.25
Today|||52-Week Range
12.88
-50.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues60.6M61.3M84.9M121.7M
 
 
 
 
 
Cost of Goods Sold16.1M23.4M43.9M45.2M
 
 
 
 
 
Depreciation And Amortization2.3M3.2M8.7M33.0M
 
 
 
 
 
 
Operating ExpensesGross Income42.2M34.7M32.3M43.6M
 
 
 
 
 
General Expenses23.1M35.6M66.6M66.1M
 
 
 
 
 
Other Operating Expenses384.9K0.000.000.00
 
 
Research And Development922.4K731.7K4.8M3.9M
 
 
 
 
 
Total Operating Expenses41.9M62.2M119.2M144.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income18.7M-848.7K-34.3M-22.5M
 
 
 
 
 
Extraordinary Credit0.000.0016.6M0.00
 
 
Extraordinary Charge-4.8M-600.5K-28.0M-7.3M
 
 
 
 
 
Pre-Tax Equity Earnings0.00-240.2K0.000.00
 
 
Interest Expense On Debt212.0K168.8K4.2M19.1M
 
 
 
 
 
Equity In Earnings-814.4K0.00----
 
 
Other Expenses0.000.003.4M-401.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income13.8M-1.8M-46.4M-49.0M
 
 
 
 
 
Income Taxes-4.6M-374.0K-20.8M-13.7M
 
 
 
 
 
Net Income8.3M-1.4M-25.6M-35.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.0M28.1M36.4M37.9M
 
 
 
 
 
Shares To Calculate EPS Diluted24.5M28.1M36.4M37.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.34-$0.05-$0.70-$0.93
 
 
 
 
 
EPS Diluted$0.34-$0.05-$0.70-$0.93